Bartlett & Co. »

Crispr Therapeutics shares owned by Bartlett & Co.

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Bartlett & Co. from 13F filings

Historical chart of Bartlett & Co. investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Bartlett & Co. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Bartlett & Co.

Quarter filed Position value Share count Share price at filing
2023-12-31 $714k 11k 64.32
2023-09-30 $504k 11k 45.41
2023-06-30 $623k 11k 56.13
2023-03-31 $502k 11k 45.23
2022-12-31 $451k 11k 40.63
2022-09-30 $725k 11k 65.32
2022-06-30 $310k 5.1k 60.78
2022-03-31 $854k 14k 62.79
2021-12-31 $1.0M 14k 75.81